Skip to content
2000
Volume 21, Issue 29
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Euglena, a microalga, has gained a great attention as it contains several bioactive compounds including food supplements, drugs and biofuels. The genus Euglena includes >300 species of unicellular, fresh water flagellates. The objective of this review article concerns the presentation of updated information on pharmacological and therapeutic properties and industrial implications of molecules isolated from Euglena species. A bibliographic search of scientific literature published till March, 2020 was made from scientific databases using different search engines. Euglena produces several antioxidant molecules, such as β-carotene, L-ascorbic acid, polymers of unsaturated fatty acids and phytotoxins useful in manufacturing many pharmaceutical, cosmetics, and nutraceutical compounds. It is a rich source of antimicrobial, anticancer, immunomodulatory compounds. Though, several studies have indicated its therapeutic applications, extensive research is needed to explore its efficacy against many pathophysiological conditions including toxicity assessment of compound(s). Nevertheless, the biotechnological influence on industrial production of Euglena has been less exploited.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026621666210813111424
2021-11-01
2025-06-23
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026621666210813111424
Loading

  • Article Type:
    Review Article
Keyword(s): Anti-HIV; Anticancer; Antimicrobial; Antioxidant; Euglena tuba; immunomodulatory
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test